title: Combined high and low dosing of OKT3 for treatment of rejection episodes in renal transplants.
authors.affiliation: Hartford Transplant Center, Hartford Hospital, Connecticut 06102-5037.
authors.forename: R T
authors.initials: RT
authors.lastname: Schweizer
authors.forename: S
authors.initials: S
authors.lastname: Bartus
authors.forename: D
authors.initials: D
authors.lastname: Hull
authors.forename: G
authors.initials: G
authors.lastname: Perdrizet
authors.forename: L
authors.initials: L
authors.lastname: Roper
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D015996:Survival Rate; D013997:Time Factors
chemical_list: D016853:Muromonab-CD3; D016572:Cyclosporine; D008775:Methylprednisolone